WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+12.81%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$18.9B
AUM Growth
+$3.55B
(+23%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
13.19%
Top 10 Holdings %
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179
Top Buys
| 1 |
Microsoft
MSFT
|
+$247M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$152M |
| 3 |
Brown & Brown
BRO
|
+$120M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$113M |
| 5 |
Akero Therapeutics
AKRO
|
+$106M |
Top Sells
| 1 |
Lam Research
LRCX
|
+$144M |
| 2 |
MetLife
MET
|
+$97.2M |
| 3 |
Travelers Companies
TRV
|
+$91.9M |
| 4 |
Electronic Arts
EA
|
+$91.9M |
| 5 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$80.3M |
Sector Composition
| 1 | Healthcare | 25.08% |
| 2 | Technology | 24.07% |
| 3 | Financials | 10.59% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KMTS
751
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$917M
| $1.67M | 0.01% |
100,718
| – | – |
|
|
CEPT
752
Cantor Equity Partners II, Inc. Class A Ordinary Share
CEPT
$321M
| $1.65M | 0.01% |
+150,000
| New | +$1.65M |
|
753
Woodward
WWD
$14.4B
| $1.63M | 0.01% |
6,633
-4,541
| -41% | -$1.11M |
|
754
Clorox
CLX
$15.4B
| $1.6M | 0.01% |
13,333
+2,926
| +28% | +$351K |
|
755
Rocket Pharmaceuticals
RCKT
$346M
| $1.6M | 0.01% |
652,865
| – | – |
|
756
Las Vegas Sands
LVS
$37.1B
| $1.6M | 0.01% |
36,689
+7,657
| +26% | +$333K |
|
757
Denali Therapeutics
DNLI
$2.25B
| $1.59M | 0.01% |
113,517
| – | – |
|
758
Torrid Holdings
CURV
$188M
| $1.55M | 0.01% |
+526,500
| New | +$1.55M |
|
759
CDW
CDW
$22B
| $1.54M | 0.01% |
8,635
-255,510
| -97% | -$45.6M |
|
760
Omnicom Group
OMC
$15.3B
| $1.52M | 0.01% |
21,104
+17,784
| +536% | +$1.28M |
|
761
Esperion Therapeutics
ESPR
$512M
| $1.48M | 0.01% |
1,503,754
| – | – |
|
762
Petco
WOOF
$1.02B
| $1.45M | 0.01% |
513,648
+64,287
| +14% | +$182K |
|
763
Old Dominion Freight Line
ODFL
$31.8B
| $1.43M | 0.01% |
+8,819
| New | +$1.43M |
|
|
JNPR
764
DELISTED
Juniper Networks
JNPR
| $1.43M | 0.01% |
35,814
+7,841
| +28% | +$313K |
|
765
KALA BIO
KALA
$102M
| $1.43M | 0.01% |
300,149
+41,383
| +16% | +$197K |
|
766
Jack Henry & Associates
JKHY
$11.9B
| $1.42M | 0.01% |
7,877
+1,718
| +28% | +$310K |
|
|
ABVX
767
Abivax
ABVX
$6.74B
| $1.41M | 0.01% |
183,800
-18,124
| -9% | -$139K |
|
768
Best Buy
BBY
$16.3B
| $1.4M | 0.01% |
20,838
+4,402
| +27% | +$296K |
|
769
Builders FirstSource
BLDR
$15.5B
| $1.39M | 0.01% |
11,954
+2,231
| +23% | +$260K |
|
770
Interpublic Group of Companies
IPG
$9.89B
| $1.39M | 0.01% |
56,944
-649,929
| -92% | -$15.9M |
|
|
SION
771
Sionna Therapeutics, Inc. Common Stock
SION
$954M
| $1.39M | 0.01% |
80,000
| – | – |
|
772
Chord Energy
CHRD
$5.9B
| $1.38M | 0.01% |
14,200
-365,845
| -96% | -$35.4M |
|
773
Tourmaline Bio
TRML
$775M
| $1.36M | 0.01% |
85,177
-74,909
| -47% | -$1.2M |
|
774
Xenon Pharmaceuticals
XENE
$2.89B
| $1.36M | 0.01% |
+43,380
| New | +$1.36M |
|
775
Aquestive Therapeutics
AQST
$602M
| $1.35M | 0.01% |
407,661
| – | – |
|